Antigen-presenting Cells in Human Endometrium During the Menstrual Cycle Compared to Early Pregnancy
Overview
Authors
Affiliations
Objective: Human endometrium and early pregnancy decidua harbor a considerable and diverse population of antigen-presenting cells (APC). Changes in the number and distribution of macrophages and dendritic cells (DC) could point to a possible role of these immunocompetent cells in implantation and success of early pregnancy.
Methods: Uterine tissue was obtained from 22 women undergoing hysterectomy for bleeding disorders or dysmenorrhea and from 11 women undergoing legal abortion. Tissue was investigated with antibodies against CD14, CD68, CD83, DC-SIGN, Ki-67, and human leukocyte antigen (HLA)-DR using single and double immunohistochemical staining techniques.
Results: The number of CD14(+) cells was stable during all phases of the menstrual cycle and early pregnancy. In comparison to nonpregnant endometrium, DC-SIGN(+) cells showed a higher proliferation rate and were found associated in clusters with CD56(+) natural killer (NK) cells in early pregnancy. In the late secretory phase of the menstrual cycle, numbers of CD83(+) (P <.01) cells were significantly higher than in other endometrial phases and early pregnancy. HLA-DR(+) expression was significantly increased in early pregnancy but remained unchanged throughout the menstrual cycle.
Conclusion: The presence of DC-SIGN(+) cells during the menstrual cycle and their proliferation in early pregnancy suggests an important role of these cells with regard to the balance between defense against pathogens and tolerance of the fetal allograft. Whether the increase of CD83(+) mature DC and CD68(+) macrophages in the late secretory phase is caused by hormonal stimuli and/or is due to changes of the cytokine/chemokine micromilieu remains to be investigated.
Lv M, Jia Y, Dong J, Wu S, Ying H Inflamm Res. 2025; 74(1):44.
PMID: 40038160 PMC: 11880140. DOI: 10.1007/s00011-025-02015-6.
Dendritic cells under the control of the preimplantation embryo secretome: an in vitro study.
Kyvelidou C, Haselrieder S, von Gierke M, Gostner J, Biasio W, Wirleitner B Reprod Biol Endocrinol. 2024; 22(1):150.
PMID: 39578791 PMC: 11585248. DOI: 10.1186/s12958-024-01319-2.
Rees A, Edwards-I-Coll Z, Richards O, Raikes M, Angelini R, Thornton C Mol Omics. 2023; 19(4):340-350.
PMID: 36883215 PMC: 10167726. DOI: 10.1039/d2mo00294a.
Rees A, Richards O, Chambers M, Jenkins B, Cronin J, Thornton C Clin Exp Immunol. 2022; 208(2):132-146.
PMID: 35348641 PMC: 9188350. DOI: 10.1093/cei/uxac003.
Jee B, Dhar R, Singh S, Karmakar S Front Cell Dev Biol. 2021; 9:648463.
PMID: 33996811 PMC: 8116900. DOI: 10.3389/fcell.2021.648463.